Drug Safety in the Limelight

FDA resolves the bar code labeling debate, releases its GMP requirements for dietary supplements, and proposes a comprehensive adverse-event reporting system.

Related Content:

Regulatory WatchPharmaceutical Technology-05-02-2003

FDA Joins Effort to Curb Drug Patent Abuses

Gamesmanship Escalates over FDA User Fee Legislation

FDA Advances Quality Initiatives to Combat Drug Shortages